CORDRAN
Drug
Almirall LLC
Total Payments
$11,700
Transactions
3
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2,500 | 2 | 2 |
| 2019 | $9,200 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,200 | 1 | 78.6% |
| Consulting Fee | $2,500 | 2 | 21.4% |
Ad
Manufacturing Companies
- Almirall LLC $11,700
Product Information
- Type Drug
- Total Payments $11,700
- Total Doctors 3
- Transactions 3
About CORDRAN
CORDRAN is a drug associated with $11,700 in payments to 3 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Almirall LLC.
Payment data is available from 2019 to 2020. In 2020, $2,500 was paid across 2 transactions to 2 doctors.
The most common payment nature for CORDRAN is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,200, 78.6% of total).